Researchers used evolutionary genetics and CRISPR gene editing tech to develop an innovative treatment for gout. The approach ...

The FDA has approved the first clinical trials for human use of genetically modified pig organs to address the severe organ ...

When there's too much uric acid in the blood, it forms crystals in the joints and the kidneys – which then leads to gout and ...

Gout – a form of arthritis caused by the build-up of uric acid crystals in joints – is one of humanity’s oldest known diseases. Now, scientists at Georgia State University, Atlanta, have ...

Scientists used CRISPR to reactivate uricase, an enzyme humans lost millions of years ago. Restoring the gene in liver cells ...

Researchers at Moffitt Cancer Center have created the first genetically engineered model of lung cancer in naked mole rats, a ...

When Will Gene Editing Help Humans? This Investor Says It's Already HappeningThe reveal came during a back-and-forth when the moderator, Fortune executive editor Adam Lashinsky, asked participants ...

Genesis has FDA approval for human trials of gene-edited pig kidneys, aiming to treat its first patient this year. This ...

Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis ...

In a striking advance that helps open the door to organ transplants from animals, researchers have created gene-edited piglets cleansed of viruses that might cause disease in humans.

Canola, for example, is a GMO and was entirely created by humans in a laboratory. Gene editing, on the other hand, does not add anything to the genome.

The future of treating disease might be gene editing, and these five stocks have the most promising technologies.